BNP Paribas

Aladom is a web portal established in France in 2008, designed to connect individuals seeking home services with various service providers. Originally launched as "the genie of home services," Aladom.fr features over 85,000 classified advertisements across more than 70 categories, including childcare, personal assistance, tutoring, cleaning, and gardening. The platform aims to facilitate the hiring process for clients looking to meet their daily needs. Since its inception, Aladom has expanded its services internationally, launching in Germany, Belgium, and the USA, and later in Spain, thereby broadening its reach and enhancing its offerings in the home services sector.

Aerospacelab is a Belgian company founded in 2017 that designs, builds, and operates small satellites equipped with high‑resolution optical sensors. Its platform captures multiple images of the same area, enabling frequent monitoring of land, infrastructure, and environmental changes. The company integrates artificial intelligence and machine learning to automate tasks such as surveying, data processing, and analysis, allowing clients to quickly interpret large volumes of imagery. Headquartered near Brussels, Aerospacelab serves customers in agriculture, forestry, urban planning, and disaster response, providing actionable insights from satellite data.

reMYND specializes in developing disease-modifying treatments for Alzheimer's, Parkinson's, diabetes, and other protein-misfolding disorders. Its proprietary platforms include ReS19-T for Alzheimer's, ReS39 for diabetes, and ReS3-T targeting neuronal hyperactivity. Additionally, it offers contract research services using its Alzheimer mouse models to assess experimental treatments' effects for clients worldwide.

iSTAR Medical specializes in developing ophthalmic implants made from biomaterials. Its flagship product is the STARflo glaucoma implant, a non-degradable, precision-pore device designed to reduce intraocular pressure in open angle glaucoma patients by enhancing natural fluid outflow. The company's products are sold through distributors worldwide and it operates from its eco-friendly R&D and manufacturing facility near Namur, Belgium.

reMYND specializes in developing disease-modifying treatments for Alzheimer's, Parkinson's, diabetes, and other protein-misfolding disorders. Its proprietary platforms include ReS19-T for Alzheimer's, ReS39 for diabetes, and ReS3-T targeting neuronal hyperactivity. Additionally, it offers contract research services using its Alzheimer mouse models to assess experimental treatments' effects for clients worldwide.

Gambit Financial Solutions is a Belgian company based in Liege, founded in 2007 by Georges Hübner and Séverine Plunus. It specializes in developing investment advice and risk management solutions, aiming to support the financial community with business solutions that simplify complex financial concepts into understandable and actionable information. The company offers portfolio optimization services and provides a digital investment platform that combines algorithmic power with expert investment knowledge.

Algonquin SA, founded in 1998 and based in Brussels, Belgium, specializes in the investment, ownership, operation, and franchising of hotels across Europe. The company manages a portfolio of 43 hotel assets, offering over 7,500 rooms with an estimated value of €1.8 billion. Approximately half of these hotels operate under Algonquin's own brands or well-known international franchises, while the remainder is managed through agreements with major international operators. Algonquin distinguishes itself by actively engaging in hotel operations, providing expertise in both daily management tasks and real estate matters. This dual role allows Algonquin to optimize operational efficiency and enhance the value of its properties, making it an attractive partner for institutional investors, family offices, and private equity firms seeking to collaborate in dedicated investment vehicles.